Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives

News

 1st April 2010 Catalent Pharma Solutions

CATALENT FORMULATION EXPERT TO PRESENT AT THE 4TH

ANNUAL IMPROVING SOLUBILITY CONFERENCE

SOMERSET, NJ – March 25, 2010 — Jeffrey E. Browne, Ph.D. Technical Director, Pharmaceutical Softgel Business Development, Catalent Pharma Solutions, will be presenting at the 4th Annual Improving Solubility Conference on March 29-30, 2010 in Philadelphia, PA.

Dr. Browne’s presentation, “How to Enhance the Bioavailability of Poorly Soluble Compounds Using Lipid-Based Formulations” will take place on Wednesday, March 31, 2010 at 9:15 AM. The presentation focuses on designing strategies for the successful development of lipid-based formulations giving due consideration to the formulation’s digestibility and dispersibility. The discussion will also examine the mechanism by which these two important formulation considerations enhance absorption. Dr. Browne will also present case studies that illustrate the importance of digestion and dispersion.

For more information or to register for the conference, visit: http://www.improvingsolubility.com/Event.aspx?id=221616.

For more information on Catalent’s softgel technologies, go to: http://www.catalent.com/softgel75.


 

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |